MENU
CDXS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Codexis (CDXS) Ownership - Who owns Codexis?
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes... Show more
Industry: #Chemicals Specialty
Profile
Industry
Chemicals Specialty
Address
200 Penobscot Drive
Phone
+1 650 421-8100
Employees
174
Web
https://www.codexis.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
207.94M
P/E Ratio
N/A
Total Cash
59.78M
Projected Growth
N/A
Total Debt
59.5M
Revenue
49.82M
Risk (Beta)
2.03
Dividend Yield
N/A
Total Cash/Share
0.72
Total Debt/Equity
N/A
Revenue/Share
0.65 USD as % of share price
Fundamentals
CDXS
Capitalization
208M
P/E Ratio
N/A
Risk (Beta)
2.03
Dividend Yield
N/A
Total Cash
59.8M
Total Cash/Share
0.72
Total Debt
59.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.65%
Revenue
49.8M
ROE
N/A
Book Value
49.6M
P/B Ratio
4.19
Cash Flow
N/A
Earnings
-0.98
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8K
Current Ratio
3.72
Current Revenue Per Employee
40122.34
Dividends Per Share - Security
N/A
EBITDA
-62.28M
Float
N/A
Float - Current
N/A
Gross Income Margin
63.78
Revenue To Assets
-53.48
Shares Held By Institutions
268M
Shares Outstanding - Current
82.8M
Total Liabilities
79.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-47.379
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biocatalytic chemical processes
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Chemicals Specialty
Address
200 Penobscot Drive
Phone
+1 650 421-8100
Employees
174
Web
https://www.codexis.com